We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIVV
226
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $77.3M | 0.09% |
1,434,200
+853,853
| +147% | +$46.7M |
|
|
UNIT
227
Uniti Group
UNIT
$2.63B
| $77M | 0.09% |
4,330,367
+788,675
| +22% | +$13M |
|
228
Accenture
ACN
$89.9B
| $77M | 0.09% |
503,016
+12,663
| +3% | +$1.84M |
|
229
Microchip Technology
MCHP
$42.8B
| $76.4M | 0.09% |
1,738,464
-52,042
| -3% | -$2.35M |
|
230
Synopsys
SNPS
$71.5B
| $75.3M | 0.09% |
882,948
-24,165
| -3% | -$2.09M |
|
231
MacroGenics
MGNX
$235M
| $74.7M | 0.09% |
3,933,906
+384,861
| +11% | +$7.18M |
|
232
KKR & Co
KKR
$89.2B
| $74.4M | 0.09% |
3,532,000
-250,893
| -7% | -$5.04M |
|
|
NSH
233
DELISTED
NuStar GP Holdings LLC
NSH
| $74.1M | 0.09% |
4,719,654
-153,044
| -3% | -$2.55M |
|
234
Plains GP Holdings
PAGP
$5.23B
| $74.1M | 0.09% |
3,375,693
-1,327,075
| -28% | -$27.9M |
|
|
MLNX
235
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $73.1M | 0.09% |
1,130,477
+125,327
| +12% | +$6.63M |
|
|
GWR
236
DELISTED
Genesee & Wyoming Inc.
GWR
| $72.3M | 0.09% |
917,934
-139,437
| -13% | -$10.4M |
|
|
TWTR
237
DELISTED
Twitter, Inc.
TWTR
| $72M | 0.09% |
3,000,726
-5,640,266
| -65% | -$116M |
|
238
Itaú Unibanco
ITUB
$91.3B
| $71.4M | 0.09% |
+11,324,829
| New | +$72.3M |
|
239
BP
BP
$113B
| $70.9M | 0.09% |
1,843,564
-37,701
| -2% | -$1.37M |
|
|
TSS
240
DELISTED
Total System Services, Inc.
TSS
| $70.6M | 0.09% |
893,087
-362,693
| -29% | -$26.4M |
|
241
Albemarle
ALB
$13.5B
| $70.5M | 0.09% |
551,298
-146,605
| -21% | -$19.9M |
|
|
SODA
242
DELISTED
SodaStream International Ltd
SODA
| $70.3M | 0.08% |
1,000,000
+600,000
| +150% | +$39.7M |
|
243
Wolfspeed
WOLF
$1.2B
| $69.9M | 0.08% |
1,882,955
+866,361
| +85% | +$29.9M |
|
244
Quest Diagnostics
DGX
$25.1B
| $69.7M | 0.08% |
707,772
+14,674
| +2% | +$1.39M |
|
|
IRBT
245
DELISTED
iRobot
IRBT
| $69.6M | 0.08% |
907,768
-107,129
| -11% | -$7.72M |
|
246
Littelfuse
LFUS
$10.2B
| $69.5M | 0.08% |
351,587
+204,842
| +140% | +$41.1M |
|
247
Teva Pharmaceuticals
TEVA
$35.9B
| $69.4M | 0.08% |
+3,663,208
| New | +$55.1M |
|
248
Ford
F
$57.3B
| $69M | 0.08% |
5,522,647
-489,354
| -8% | -$6.03M |
|
|
ATVI
249
DELISTED
Activision Blizzard
ATVI
| $68.5M | 0.08% |
1,081,385
-69
| -0% | -$4.36K |
|
250
First Solar
FSLR
$21.8B
| $68.4M | 0.08% |
1,012,954
+726,830
| +254% | +$42.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.